Symbols / STIM $1.52 -13.64% Neuronetics, Inc.

Healthcare • Medical Devices • United States • NGM
STIM Chart
About

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 105.30M
Enterprise Value 171.33M Income -39.00M Sales 149.16M
Book/sh 0.32 Cash/sh 0.41 Dividend Yield
Payout 0.00% Employees 658 IPO
P/E Forward P/E -4.75 PEG
P/S 0.71 P/B 4.69 P/C
EV/EBITDA -6.20 EV/Sales 1.15 Quick Ratio 1.47
Current Ratio 2.02 Debt/Eq 344.14 LT Debt/Eq
EPS (ttm) -0.59 EPS next Y -0.32 EPS Growth
Revenue Growth 85.70% Earnings 2026-05-05 ROA -13.73%
ROE -134.86% ROIC Gross Margin 48.75%
Oper. Margin -11.11% Profit Margin -26.15% Shs Outstand 69.28M
Shs Float 28.16M Short Float 23.10% Short Ratio 8.87
Short Interest 52W High 4.85 52W Low 0.80
Beta 0.87 Avg Volume 2.18M Volume 2.35M
Target Price $4.33 Recom None Prev Close $1.76
Price $1.52 Change -13.64%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$4.33
Mean price target
2. Current target
$1.56
Latest analyst target
3. DCF / Fair value
$-2.71
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.56
Low
$3.00
High
$7.00
Mean
$4.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-19 main Canaccord Genuity Buy → Buy $3
2025-08-06 main Canaccord Genuity Buy → Buy $7
2025-03-05 main Canaccord Genuity Buy → Buy $8
2025-03-05 main Citizens Capital Markets Market Outperform → Market Outperform $7
2024-08-14 main JMP Securities Market Outperform → Market Outperform $3
2024-08-13 main Canaccord Genuity Buy → Buy $3
2024-08-12 down William Blair Outperform → Market Perform
2024-05-14 up William Blair Market Perform → Outperform
2024-03-06 reit Piper Sandler Overweight → Overweight $8
2023-05-10 reit JMP Securities — → Market Outperform $12
2023-03-08 main Canaccord Genuity — → Buy $7
2023-03-08 reit JMP Securities — → Market Outperform $12
2021-10-14 main JMP Securities — → Market Outperform $12
2021-10-13 down BTIG Buy → Neutral
2021-01-22 up William Blair Market Perform → Outperform
2020-10-26 main Canaccord Genuity — → Buy $8
2020-10-06 reit BTIG — → Buy $10
2020-04-09 main Canaccord Genuity — → Buy $4
2019-11-06 main JMP Securities — → Market Outperform $12
2018-08-15 main JMP Securities Market Outperform → Market Outperform $40
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-30 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security 385,442 $1.25 $481,802
2026-03-27 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security 500,000 $1.35 $675,000
2026-03-26 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security 150,000 $1.40 $211,000
2026-03-23 REUVERS DANIEL L Chief Executive Officer 1,500,000 $0.00 $0
2026-03-20 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security 169,472 $1.41 $238,956
2026-03-19 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security 1,057,400 $1.33 $1,418,490
2026-03-19 SULLIVAN KEITH J Former 46,289 $1.34 $62,027
2026-03-19 MACAN WILLIAM ANDREW Officer 16,005 $1.34 $21,447
2026-03-19 PFANSTIEL STEVEN Chief Financial Officer 16,431 $1.34 $22,018
2026-03-17 SULLIVAN KEITH J Chief Executive Officer 112,500 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
149.16
+99.17%
74.89
+4.96%
71.35
+9.42%
65.21
Operating Revenue
149.16
+99.17%
74.89
+4.96%
71.35
+9.42%
65.21
Cost Of Revenue
76.85
+270.73%
20.73
+5.53%
19.64
+26.87%
15.48
Reconciled Cost Of Revenue
76.85
+270.73%
20.73
+5.53%
19.64
+26.87%
15.48
Gross Profit
72.31
+33.51%
54.16
+4.75%
51.70
+3.99%
49.72
Operating Expense
103.74
+16.93%
88.72
+7.86%
82.26
-3.04%
84.83
Research And Development
6.58
-48.45%
12.77
+34.22%
9.52
+1.92%
9.34
Selling General And Administration
97.16
+27.92%
75.95
+4.41%
72.74
-3.65%
75.50
Selling And Marketing Expense
47.46
+4.00%
45.63
-3.57%
47.32
-5.33%
49.98
General And Administrative Expense
49.70
+63.91%
30.32
+19.26%
25.43
-0.35%
25.52
Other Gand A
49.70
+63.91%
30.32
+19.26%
25.43
-0.35%
25.52
Total Expenses
180.59
+65.00%
109.45
+7.41%
101.90
+1.58%
100.32
Operating Income
-31.44
+9.05%
-34.56
-13.12%
-30.55
+12.98%
-35.11
Total Operating Income As Reported
-31.44
+9.05%
-34.56
-13.12%
-30.55
+12.98%
-35.11
EBITDA
-28.05
+20.23%
-35.17
-50.55%
-23.36
+26.91%
-31.96
Normalized EBITDA
-28.05
+8.74%
-30.74
-31.60%
-23.36
+26.91%
-31.96
Reconciled Depreciation
3.46
+67.15%
2.07
+3.34%
2.01
+21.72%
1.65
EBIT
-31.52
+15.36%
-37.24
-46.82%
-25.36
+24.53%
-33.61
Total Unusual Items
0.00
+100.00%
-4.43
0.00
0.00
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-4.43
0.00
0.00
Special Income Charges
0.00
+100.00%
-4.43
0.00
0.00
Other Special Charges
4.43
Net Income
-39.00
+10.78%
-43.71
-44.78%
-30.19
+18.76%
-37.16
Pretax Income
-39.12
+10.56%
-43.74
-45.01%
-30.16
+18.93%
-37.21
Net Non Operating Interest Income Expense
-8.40
-15.07%
-7.30
-35.19%
-5.40
-25.58%
-4.30
Interest Expense Non Operating
7.60
+16.92%
6.50
+35.42%
4.80
+33.33%
3.60
Net Interest Income
-8.40
-15.07%
-7.30
-35.19%
-5.40
-25.58%
-4.30
Interest Expense
7.60
+16.92%
6.50
+35.42%
4.80
+33.33%
3.60
Other Income Expense
0.72
+138.13%
-1.88
-132.44%
5.79
+162.78%
2.20
Other Non Operating Income Expenses
0.72
-71.91%
2.55
-55.97%
5.79
+162.78%
2.20
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-39.12
+10.56%
-43.74
-45.01%
-30.16
+18.93%
-37.21
Net Income From Continuing Operation Net Minority Interest
-39.00
+10.78%
-43.71
-44.78%
-30.19
+18.76%
-37.16
Net Income From Continuing And Discontinued Operation
-39.00
+10.78%
-43.71
-44.78%
-30.19
+18.76%
-37.16
Net Income Continuous Operations
-39.12
+10.56%
-43.74
-45.01%
-30.16
+18.93%
-37.21
Minority Interests
0.14
+621.05%
0.02
0.00
0.00
Normalized Income
-39.00
+0.72%
-39.28
-30.12%
-30.19
+18.76%
-37.16
Net Income Common Stockholders
-39.00
+10.78%
-43.71
-44.78%
-30.19
+18.76%
-37.16
Diluted EPS
-1.37
-30.48%
-1.05
+23.91%
-1.38
Basic EPS
-1.37
-30.48%
-1.05
+23.91%
-1.38
Basic Average Shares
31.63
+10.36%
28.66
+6.54%
26.90
Diluted Average Shares
31.63
+10.36%
28.66
+6.54%
26.90
Diluted NI Availto Com Stockholders
-39.00
+10.78%
-43.71
-44.78%
-30.19
+18.76%
-37.16
Total Other Finance Cost
0.80
+0.00%
0.80
+33.33%
0.60
-14.29%
0.70
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
141.55
+0.46%
140.90
+21.65%
115.83
-0.90%
116.88
Current Assets
61.55
+5.90%
58.12
-38.03%
93.79
-5.04%
98.77
Cash Cash Equivalents And Short Term Investments
28.36
+51.94%
18.66
-69.19%
60.58
-15.72%
71.88
Cash And Cash Equivalents
28.13
+52.41%
18.46
-69.07%
59.68
-15.16%
70.34
Other Short Term Investments
0.23
+9.22%
0.21
-77.24%
0.91
-41.16%
1.54
Receivables
16.89
-30.44%
24.29
+36.14%
17.84
+29.06%
13.82
Accounts Receivable
16.47
-29.48%
23.36
+47.99%
15.78
+16.12%
13.59
Gross Accounts Receivable
17.51
-30.74%
25.29
+52.53%
16.58
+8.78%
15.24
Allowance For Doubtful Accounts Receivable
-1.04
+45.96%
-1.93
-142.77%
-0.80
+51.76%
-1.65
Inventory
4.33
+1.86%
4.25
-47.51%
8.09
-9.06%
8.90
Prepaid Assets
3.05
-0.91%
3.08
+22.43%
2.51
+25.89%
2.00
Restricted Cash
6.00
+500.00%
1.00
0.00
Other Current Assets
2.92
-57.32%
6.85
+43.64%
4.77
+119.23%
2.17
Total Non Current Assets
80.00
-3.36%
82.78
+275.63%
22.04
+21.66%
18.11
Net PPE
28.03
-15.93%
33.34
+597.09%
4.78
-10.08%
5.32
Gross PPE
32.08
-12.30%
36.58
+381.05%
7.60
-9.21%
8.38
Accumulated Depreciation
-4.05
-24.91%
-3.24
-14.95%
-2.82
+7.69%
-3.06
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.39
-77.00%
6.05
+278.06%
1.60
-29.39%
2.27
Other Properties
29.08
+0.54%
28.92
+533.14%
4.57
-2.27%
4.67
Leases
1.61
+0.00%
1.61
+11.98%
1.44
+0.07%
1.44
Goodwill And Other Intangible Assets
41.77
+9.23%
38.24
0.00
Goodwill
23.62
+26.77%
18.63
0.00
Other Intangible Assets
18.15
-7.43%
19.61
Investments And Advances
0.10
+13.95%
0.09
-86.99%
0.66
-45.91%
1.22
Other Investments
0.10
+13.95%
0.09
-86.99%
0.66
-45.91%
1.22
Non Current Prepaid Assets
7.97
-10.45%
8.90
+6.36%
8.37
+10.60%
7.57
Other Non Current Assets
1.98
+3.07%
1.92
-56.59%
4.43
+21.54%
3.65
Total Liabilities Net Minority Interest
115.31
+5.69%
109.10
+33.64%
81.64
+36.47%
59.82
Current Liabilities
30.52
-2.38%
31.27
+57.81%
19.81
-40.32%
33.20
Payables And Accrued Expenses
15.10
-8.77%
16.55
+77.10%
9.34
+53.96%
6.07
Payables
12.00
-2.43%
12.30
+120.84%
5.57
+80.14%
3.09
Accounts Payable
10.74
-3.05%
11.08
+133.10%
4.75
+95.31%
2.43
Other Payable
0.65
+7.77%
0.60
Current Accrued Expenses
3.10
-27.13%
4.25
+12.53%
3.77
+26.77%
2.98
Pensionand Other Post Retirement Benefit Plans Current
8.61
+8.27%
7.95
-0.64%
8.00
-28.55%
11.20
Total Tax Payable
0.61
-1.29%
0.62
-24.33%
0.82
+24.13%
0.66
Current Debt And Capital Lease Obligation
5.56
+16.07%
4.79
+466.98%
0.84
-93.94%
13.95
Current Debt
13.12
Other Current Borrowings
13.12
Current Capital Lease Obligation
5.56
+16.07%
4.79
+466.98%
0.84
+2.55%
0.82
Current Deferred Liabilities
1.25
-36.52%
1.97
+21.85%
1.62
-18.18%
1.98
Current Deferred Revenue
0.75
-22.69%
0.97
-39.88%
1.62
-18.18%
1.98
Total Non Current Liabilities Net Minority Interest
84.79
+8.93%
77.84
+25.89%
61.83
+132.22%
26.62
Long Term Debt And Capital Lease Obligation
84.74
+8.87%
77.84
+26.30%
61.63
+138.91%
25.80
Long Term Debt
65.81
+19.32%
55.15
-6.97%
59.28
+159.68%
22.83
Long Term Capital Lease Obligation
18.93
-16.53%
22.69
+867.01%
2.35
-20.93%
2.97
Non Current Deferred Liabilities
0.05
+2300.00%
0.00
-99.00%
0.20
-75.87%
0.83
Non Current Deferred Revenue
0.05
+2300.00%
0.00
-99.00%
0.20
-75.87%
0.83
Stockholders Equity
22.38
-19.23%
27.71
-18.96%
34.19
-40.08%
57.06
Common Stock Equity
22.38
-19.23%
27.71
-18.96%
34.19
-40.08%
57.06
Capital Stock
0.69
+23.88%
0.56
+91.41%
0.29
+6.59%
0.27
Common Stock
0.69
+23.88%
0.56
+91.41%
0.29
+6.59%
0.27
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
68.99
+23.91%
55.68
+91.40%
29.09
+6.69%
27.27
Ordinary Shares Number
68.99
+23.91%
55.68
+91.40%
29.09
+6.69%
27.27
Additional Paid In Capital
480.48
+7.50%
446.94
+9.01%
409.98
+1.81%
402.68
Retained Earnings
-458.79
-9.29%
-419.79
-11.62%
-376.08
-8.73%
-345.89
Minority Interest
3.86
-5.64%
4.09
0.00
Total Equity Gross Minority Interest
26.24
-17.48%
31.80
-6.99%
34.19
-40.08%
57.06
Total Capitalization
88.19
+6.43%
82.86
-11.36%
93.47
+17.00%
79.89
Working Capital
31.03
+15.54%
26.86
-63.70%
73.98
+12.83%
65.57
Invested Capital
88.19
+6.43%
82.86
-11.36%
93.47
+0.49%
93.01
Total Debt
90.30
+9.29%
82.63
+32.26%
62.47
+57.19%
39.74
Net Debt
37.67
+2.67%
36.69
Capital Lease Obligations
24.50
-10.85%
27.48
+761.08%
3.19
-15.83%
3.79
Net Tangible Assets
-19.39
-84.10%
-10.53
-130.81%
34.19
-40.08%
57.06
Tangible Book Value
-19.39
-84.10%
-10.53
-130.81%
34.19
-40.08%
57.06
Current Provisions
Non Current Note Receivables
0.15
-48.81%
0.29
-92.23%
3.79
+948.34%
0.36
Notes Receivable
0.42
-54.41%
0.93
-54.77%
2.06
+793.91%
0.23
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-20.37
+34.27%
-31.00
+3.25%
-32.04
-4.23%
-30.74
Cash Flow From Continuing Operating Activities
-20.37
+34.27%
-31.00
+3.25%
-32.04
-4.23%
-30.74
Net Income From Continuing Operations
-39.13
+10.50%
-43.73
-44.84%
-30.19
+18.76%
-37.16
Depreciation Amortization Depletion
3.46
+67.15%
2.07
+3.34%
2.01
+21.72%
1.65
Depreciation And Amortization
3.46
+67.15%
2.07
+3.34%
2.01
+21.72%
1.65
Other Non Cash Items
0.82
+6.87%
0.77
+21.61%
0.63
-20.85%
0.80
Stock Based Compensation
6.85
+22.24%
5.60
-23.46%
7.32
-16.32%
8.75
Provisionand Write Offof Assets
0.59
-71.44%
2.06
+426.92%
0.39
+14.37%
0.34
Asset Impairment Charge
0.39
-91.53%
4.58
+140.52%
1.91
0.00
Operating Gains Losses
0.07
-98.38%
4.46
Gain Loss On Sale Of PPE
0.07
+157.14%
0.03
0.00
0.00
Change In Working Capital
6.58
+196.61%
-6.81
+51.73%
-14.10
-175.66%
-5.12
Change In Receivables
3.54
+195.01%
-3.73
+57.80%
-8.83
-32.64%
-6.66
Changes In Account Receivables
3.54
+195.01%
-3.73
+57.80%
-8.83
-32.64%
-6.66
Change In Inventory
-0.40
-112.54%
3.15
+386.89%
-1.10
+57.56%
-2.59
Change In Prepaid Assets
5.63
+350.20%
-2.25
+45.94%
-4.16
-811.16%
-0.46
Change In Payables And Accrued Expense
-2.25
+44.64%
-4.07
-1800.93%
-0.21
-104.62%
4.64
Change In Accrued Expense
-0.50
+75.90%
-2.08
+7.13%
-2.24
-133.96%
6.60
Change In Payable
-1.75
+11.84%
-1.99
-197.83%
2.03
+203.10%
-1.97
Change In Account Payable
-1.75
+11.84%
-1.99
-197.83%
2.03
+203.10%
-1.97
Change In Other Working Capital
-0.17
+79.24%
-0.84
+14.76%
-0.99
+15.03%
-1.16
Change In Other Current Assets
-0.03
-103.11%
1.00
-16.43%
1.19
+7.09%
1.11
Change In Other Current Liabilities
0.26
+489.39%
-0.07
0.00
0.00
Investing Cash Flow
-0.80
+66.80%
-2.41
-82.53%
-1.32
-119.64%
6.73
Cash Flow From Continuing Investing Activities
-0.80
+66.80%
-2.41
-82.53%
-1.32
-119.64%
6.73
Net PPE Purchase And Sale
-0.80
+45.36%
-1.47
+38.12%
-2.37
+27.53%
-3.27
Purchase Of PPE
-0.80
+45.36%
-1.47
+38.12%
-2.37
+27.53%
-3.27
Capital Expenditure
-0.80
+45.36%
-1.47
+38.12%
-2.37
+27.53%
-3.27
Net Investment Purchase And Sale
10.00
Net Business Purchase And Sale
0.00
+100.00%
-2.55
0.00
0.00
Purchase Of Business
0.00
+100.00%
-2.55
0.00
0.00
Net Other Investing Changes
1.61
+53.39%
1.05
-89.53%
10.00
Financing Cash Flow
35.85
+626.59%
-6.81
-130.00%
22.70
+10864.73%
0.21
Cash Flow From Continuing Financing Activities
35.85
+626.59%
-6.81
-130.00%
22.70
+10864.73%
0.21
Net Issuance Payments Of Debt
9.79
+488.30%
-2.52
-110.59%
23.80
0.00
Issuance Of Debt
10.00
-82.60%
57.48
+129.92%
25.00
0.00
Repayment Of Debt
-0.21
+99.65%
-60.00
-4900.00%
-1.20
0.00
Long Term Debt Issuance
10.00
-82.60%
57.48
+129.92%
25.00
0.00
Long Term Debt Payments
-0.21
+99.65%
-60.00
-4900.00%
-1.20
0.00
Net Long Term Debt Issuance
9.79
+488.30%
-2.52
-110.59%
23.80
0.00
Net Common Stock Issuance
27.28
0.00
0.00
0.00
Common Stock Payments
-1.73
0.00
0.00
Repurchase Of Capital Stock
-1.73
0.00
0.00
Proceeds From Stock Option Exercised
0.01
-99.48%
2.52
+252100.00%
0.00
-99.66%
0.30
Net Other Financing Charges
-1.23
+81.88%
-6.81
-516.76%
-1.10
-1113.19%
-0.09
Changes In Cash
14.68
+136.49%
-40.22
-277.17%
-10.66
+55.20%
-23.80
Beginning Cash Position
19.46
-67.39%
59.68
-15.16%
70.34
-25.28%
94.14
End Cash Position
34.13
+75.41%
19.46
-67.39%
59.68
-15.16%
70.34
Free Cash Flow
-21.18
+34.77%
-32.46
+5.65%
-34.41
-1.17%
-34.01
Interest Paid Supplemental Data
7.59
+16.55%
6.51
+35.97%
4.79
+35.20%
3.54
Common Stock Issuance
29.01
0.00
0.00
0.00
Issuance Of Capital Stock
29.01
0.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category